Effect of Bone Morphogenetic Protein-2 Combined With Microfracture for Osteochondral Defect of the Talus in a Rabbit Model

被引:4
|
作者
Dang, Le Hoang Nam [1 ]
Tran, Nhat Tien [2 ,3 ]
Oh, Jong-Sung [2 ]
Kwon, Tae-Young [2 ,4 ]
Lee, Kwang-Bok [2 ,4 ]
机构
[1] Hue Univ, Hue Univ Med & Pharm, Dept Anat Surg Training, Hue, Vietnam
[2] Jeonbuk Natl Univ, Jeonbuk Natl Univ Hosp, Biomed Res Inst, Med Sch,Res Inst Clin Med,Dept Orthoped Surg, Jeonju, South Korea
[3] Hue Univ, Hue Univ Med & Pharm, Dept Surg, Hue, Vietnam
[4] Jeonbuk Natl Univ Hosp, Dept Orthoped Surg, Jeonju 63418, Jeonbuk, South Korea
来源
AMERICAN JOURNAL OF SPORTS MEDICINE | 2023年 / 51卷 / 06期
关键词
rhBMP-2; hydroxyapatite; microfracture; osteochondral defect; talus; ARTICULAR-CARTILAGE DEFECTS; FULL-THICKNESS DEFECTS; ARTHROSCOPIC TREATMENT; GROWTH-FACTORS; LESIONS; CHONDROGENESIS; HYDROXYAPATITE; HEPARIN; MATRIX; REGENERATION;
D O I
10.1177/03635465231162316
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background: Osteochondral defects of the talus can be effectively treated using microfracture, which is technically safe, accessible, and affordable. However, fibrous tissue and fibrocartilage comprise the majority of tissue repairs resulting from these procedures. These tissue types lack the mechanical characteristics of native hyaline cartilage and might significantly contribute to the decline in long-term outcomes. Recombinant human-bone morphogenetic protein-2 (rhBMP-2) has been shown to promote matrix synthesis and increase cartilage formation, thus enhancing chondrogenesis in vitro. Purpose: This study aimed to evaluate the treatment ability of combining rhBMP-2 with microfracture in rabbit talus osteochondral defect. Study Design: Controlled laboratory study. Methods: A full-thickness chondral defect (3 x 3 x 2 mm) was constructed in the center talar dome of 24 New Zealand White male rabbits, which were then divided into 4 groups of 6. Each group received the appropriate treatment: group 1 (control; no treatment of defect), group 2 (microfracture treatment), group 3 (rhBMP-2/hydroxyapatite treatment), and group 4 (microfracture combined with rhBMP-2/hydroxyapatite treatment). Animals were sacrificed at 2, 4, and 6 weeks postoperatively. The International Cartilage Regeneration & Joint Preservation Society macroscopic score, which considers the degree of defect repair, the integration to the border zone, and the macroscopic appearance, was used to assess the repaired tissue's macroscopic appearance. Subchondral bone regeneration in defects was analyzed using micro-computed tomography, and the histological findings were graded using a modified version of the Wakitani scoring system for osteochondral repair. Results: At 2, 4, and 6 weeks, micro-computed tomography analysis revealed that groups 3 and 4 exhibited subchondral bone healing that was more significantly improved compared with groups 1. No sample showed excessive bone growth from the subchondral bone area. According to macroscopic and histological results, group 4 showed higher-quality cartilage and more accelerated cartilage regeneration than the other groups over time. Conclusion: These findings show that osteochondral defect repair in a rabbit talus model could be effectively accelerated and improved by combining rhBMP-2 with microfracture.
引用
收藏
页码:1560 / 1570
页数:11
相关论文
共 50 条
  • [1] The Effects of Microfracture and Bone Morphogenetic Protein-2 on the Healing of Articular Cartilage Defect of the Rabbit
    Lee, Seoung Joon
    Kim, Hak Jun
    Yang, Hee Seok
    Kim, Byung Soo
    Park, Jung Ho
    TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2009, 6 (13) : 1224 - 1232
  • [2] Effect of bone morphogenetic protein-2/hydroxyapatite on ankle fusion with bone defect in a rabbit model: a pilot study
    Dang, Le Hoang Nam
    Lee, Kwang Bok
    JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH, 2020, 15 (01)
  • [3] Effect of bone morphogenetic protein-2/hydroxyapatite on ankle fusion with bone defect in a rabbit model: a pilot study
    Le Hoang Nam Dang
    Kwang Bok Lee
    Journal of Orthopaedic Surgery and Research, 15
  • [4] Heparin increases the osteogenic effect of recombinant human bone morphogenetic protein-2 in the rabbit bone defect model
    Ban, Ju Yeon
    Kang, Sang Wook
    Park, Gyeong-Ju
    ANIMAL CELLS AND SYSTEMS, 2015, 19 (05) : 312 - 320
  • [5] Use of bone morphogenetic protein-2 in the rabbit ulnar nonunion model
    Bostrom, M
    Lane, JM
    Tomin, E
    Browne, M
    Berberian, W
    Turek, T
    Smith, J
    Wozney, J
    Schildhauer, T
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 1996, (327) : 272 - 282
  • [6] Repair of Osteochondral Defects in a Rabbit Model Using a Porous Hydroxyapatite Collagen Composite Impregnated With Bone Morphogenetic Protein-2
    Taniyama, Takashi
    Masaoka, Tomokazu
    Yamada, Tsuyoshi
    Wei, Xuetao
    Yasuda, Hiroaki
    Yoshii, Toshitaka
    Kozaka, Yuko
    Takayama, Tomoji
    Hirano, Masahiro
    Okawa, Atsushi
    Sotome, Shinichi
    ARTIFICIAL ORGANS, 2015, 39 (06) : 529 - 535
  • [7] Bone regeneration by recombinant human bone morphogenetic protein-2 and a novel biodegradable carrier in a rabbit ulnar defect model
    Kokubo, S
    Fujimoto, R
    Yokota, S
    Fukushima, S
    Nozaki, K
    Takahashi, K
    Miyata, K
    BIOMATERIALS, 2003, 24 (09) : 1643 - 1651
  • [8] Histomorphological Investigation of Microfracture Location in a Rabbit Osteochondral Defect Model
    Kilic, Ali Ihsan
    Hapa, Onur
    Ozmanevra, Ramadan
    Pak, Theresa
    Akokay, Pinar
    Ergur, Bekir Ugur
    Kosay, Mustafa Can
    AMERICAN JOURNAL OF SPORTS MEDICINE, 2023, 51 (11): : 3025 - 3034
  • [9] Recombinant human bone morphogenetic protein-2 as an osteoinductive biomaterial and a biodegradable carrier in a rabbit ulnar defect model
    Kokubo, Satoshi
    Nozaki, Kazutoshi
    Fukushima, Shinji
    Takahashi, Koichiro
    Miyata, Keiji
    Fujimoto, Ryuhei
    Yokota, Shoji
    JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS, 2008, 23 (04) : 348 - 366
  • [10] Recombinant human bone morphogenetic protein-2 as an osteoinductive biomaterial and a biodegradable carrier in a rabbit ulnar defect model
    Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd., 21 Miyukigaoka, Tsukuba, Ibaraki, 305-8585, Japan
    不详
    不详
    J. Bioact. Compat. Polym., 1600, 4 (348-366):